OBJECTIVE: To investigate whether there is a defect in the post-b-receptor signaling pathway in isolated hearts of obese, hypertensive rabbits compared with their lean, normotensive counterparts. DESIGN: Female New Zealand white rabbits were fed a maintenance (n 5) or a 10% fat diet (n 6) for 12 weeks. MEASUREMENTS: After 12 weeks, rabbits were weighed and resting blood pressure and heart rate measured in the conscious animal using a central ear artery catheter. The isolated heart preparation was used to measure peak developed pressure, peak rate of pressure rise ( dPadt), and peak rate of pressure decline ( 7 dPadt) under control and 10 76 M forskolin-stimulated conditions. RESULTS: In response to forskolin, developed pressure increased 55% in lean rabbits, but only 18% in obese rabbits. Similarly, the increase in dPadt in response to forskolin was attenuated in obese rabbits ( 52%) compared with lean rabbits ( 121%). Relaxation ( 7 dPadt) in response to forskolin was also impaired, increasing 113% in lean rabbits but only 58% in obese rabbits. CONCLUSIONS: Since forskolin bypasses the b-receptor to directly stimulate adenylate cyclase, these results suggest that obesity-hypertension is associated with a defect in post-b-receptor signaling pathways.
Introduction
Obesity is associated with a hyperdynamic circulatory state characterized by hypertension, increased cardiac output, increased intravascular volume and an increased tissue metabolic demand. These adaptations to excess body fat increase both preload and afterload on the heart. As a result, systolic function may become compromised and the risk of developing congestive heart failure increased. 1 Decrements in systolic function in obesity include lower ejection fraction, 2 peak ejection rate, 2 and fractional shortening, 3 and higher end systolic diameter. 3 This represents a serious health problem in the United States since it is estimated that approximately 35% of Americans aged 20 ± 74 are overweight. 4 Despite these statistics, there is limited information on mechanisms of cardiac contractile dysfunction in obesity. Abnormal systolic cardiac function has been identi®ed and studied in hypertensive models of cardiac function, such as aortic banding, geneticallyassociated hypertension, and renovascular hypertension. 5 ± 8 However, because obesity results in distinctly different cardiovascular adaptations compared with hypertension, 1, 9 conclusions regarding its impact on heart function cannot necessarily be deducted from the body of literature developed from other models of heart disease. Using the rabbit model of obesity, which mimics many of the characteristics of human obesity, including hypertension, resting tachycardia, left ventricular (LV) hypertrophy and neurohumoral activation, 10 we previously determined that systolic contractile function in obesity was associated with decreased response to isoproterenol both in isolated heart and isolated papillary muscle preparations. 11 However, that study did not determine whether the defect in contractile response in obesity was due to a defect in b-receptor number or in one or more post-receptor components. In the present study, we used the isolated heart preparation to determine the contractile responses of isolated hearts of lean and obese rabbits to 10 76 M forskolin infusion. Since forskolin bypasses the breceptor to directly stimulate adenylate cyclase, the present study tested the hypothesis that obesity is associated with a defect in a post-receptor signaling pathway.
Methods

Animals
The experimental protocols for this study were approved by the Institutional Animal Care and Use Committee of the University of Mississippi Medical Center. All animal care and use programs were carried out according to the Guide for the Care and Use of Laboratory Animals (National Academy Press, Washington DC, 1996) and regulations of the Animal Welfare Act. Adult female New Zealand White rabits were randomly divided into two groups, one designated to remain lean (n 5) and the other to become obese (n 6). The lean groups consumed 100 ± 120 gad standard laboratory rabbit chow, while the obese groups were given an ad libitum high fat diet, consisting of the standard chow with 10% added fat. The excess fat in the diet consisted of two-thirds corn oil and one-third lard. Experiments were performed after the rabbits had been on their respective diets for 12 weeks.
Resting haemodynamics
Resting measurement of blood pressure and heart rate was performed as described previously. 10 On the day of the experiment, the rabbit was restrained in a Plexiglas holder (Plas Labs, Lansing, MI). The central auricular artery was cannulated (PE-50 tubing, Becton Dickinson and Company, Parsippany, NJ) using 0.25% bupivacaine as a local anesthetic. The rear and neck restraints were loosened and the rabbit was allowed to sit quietly for 60 ± 90 min. Blood pressure was recorded directly from the arterial catheter using a pressure transducer positioned at heart level. The reported values were taken during the last half hour of recording, while the rabbit was in a quiet, resting state.
Isolated heart experiment
General anaesthesia was induced in the rabbits with a diazapam (7.5 mgakg)aketamine (25 ± 30 mgakg) mixture administered intravenously. An endotracheal tube was positioned in the trachea for subsequent mechanical ventilation using a Harvard Respiratory Pump. A midline thoracotomy was performed, the superior and inferior vena cavea identi®ed and isolated, and silk sutures placed around these vessels. The heart was then subjected to cardioplegic arrest and prepared for the Langendorff preparation, as described previously. 11 After the heart was dissected free, it was placed in iced Euro-Collins solution. The mitral valve was excised and a latex balloon containing a high-®delity micromanometer (Konigsberg Instruments, Pasadena, CA) was positioned in the left ventricle. The heart was then placed in an organ bath and perfused in a retrograde fashion through a cannula in the aortic root, using a modi®ed Krebs-Henseleit solution. The perfusate consisted of (in mmolal) NaCl, 115.0; NaHCO 3 , 20.0; Kcl, 4.0; K 2 HPO 4 , 0.9; MgSO 4 1.1; CaCl, 2.5; and glucose 11.0, oxygenated with a 95% O 2 a5% CO 2 mixture (pH 7.4), and maintained at a temperature of 37 C . Cardiac contractile responsiveness was evaluated using the Langendorff isolated heart preparation by determining the peak developed pressure, peak dPadt and peak 7 dPadt responses under control and 10 76 M forskolin conditions. Using customized software, signals from the high ®delity micromanometer within the latex balloon were sampled six times each minute at 250 Hz for a duration of 6 s each and immediately processed to detect peak pressure, end-diastolic pressure, dPadt and 7 dPadt. Developed pressure was calculated as peak pressure minus end-diastolic pressure. A Cobe transducer (Lakewood, CO) was positioned at the level of the aortic valve to measure perfusion pressure, which was maintained at approximately 70 mmHg. Hearts were paced by an external pacemaker at a constant rate of 180 beatsamin, similar to the resting heart rate of lean rabbits. 10 After initiating retrograde heart perfusion, heart function was allowed to stabilize for approx 30 min. Volume was added to the balloon to achieve an end diastolic pressure of approximately 0 mmHg; measurements of peak pressure, end diastolic pressure, dPadt and 7 dPadt were then recorded.
For the forskolin infusion, forskolin was ®rst dissolved in dimethyl su¯oxide (DMSO) prior to dilution to 10 76 M in Krebs buffer. In order to assure that DMSO did not signi®cantly affect contractile responses, the protocol began with a 10 min control infusion period using a DMSOaKrebs mixture without forskolin. This was followed by the 10 min forskolin infusion where the ®nal concentration of forskolin was 10 76 M. In both instances, the concentration of DMSO in the infusate was 0.2%. Developed pressure, dPadt and 7 dPadt were averaged every minute. DMSO control values used were those recorded during the ®nal minute of the 10 min infusion period. Peak forskolin values used were the highest minute average during the 10 min infusion period.
Statistical analyses
Differences between lean and obese rabits in body weight, resting haemodynamics, and ventricular weights were analyzed using analysis of variance (ANOVA) (JMP, SAS Institute, Inc., Cary, NC). For developed pressure, dPadt, and 7 dPadt measured during isolated heart experiments, the difference between peak forskolin value and DMSO control values was calculated and groups compared using ANOVA. Within-group responses to forskolin infusion were analyzed using a paired t-test. Signi®cance was accepted at 0.05. All data are expressed as mean AE s.e.m.
Results
Characteristics of lean and obese rabbits
Rabbits eating the high fat diet for 12 weeks developed signi®cant obesity, hypertension, resting tachycardia, and LV and right ventricular (RV) hypertrophy, compared to their lean counterparts. Body weight was higher by 49% in obese rabbits (5.44 AE 0.14 kg vs 3.64 AE 0.16 kg; P 0.0001). Mean blood pressure was modestly, but signi®cantly, higher by 10% in obese rabbits (94AE 2 mmHg vs 85 AE 2 mmHg; P 0.01), while resting heart rate in obese rabbits was 28% higher (230 AE 0 bpm vs 179AE 10 bpm; P 0.01). In addition, LV and RV wet weights were higher in obese rabbits by 28% (7.96 AE 0.50 g vs 6.24 AE 0.55 g; P 0.05) and 46% (2.46 AE 0.09 g vs 1.68AE 0.10 g; P 0.01), respectively.
Responses to forskolin
Under DMSO control conditions, there was no signi®cant difference between lean and obese rabbits in developed pressure, dPadt or 7 dPadt (Table 1) . With forskolin stimulation, peak developed pressure increased signi®cantly in both lean and obese rabbits. However, the difference between control and peak forskolin values was signi®cantly greater in lean rabbits than in obese rabbits (P 0.01). Normalized for LV weight, the difference between control and peak forskolin values was also greater in lean than in obese rabbits (4.8AE 0.8 mmHgag vs 1.3 AE 0.3 mmHgag; P 0.001). Contractility and relaxation, as estimated by dPadt and 7 dPadt, respectively, were reduced in the obese rabbits in response to forskolin (Table 1) . With forskolin stimulation, lean and obese rabbits demonstrated increases in both dPadt and 7 dPadt. However, the differences between control and peak forskolin values were signi®cantly greater in lean than in obese rabbits (Table 1 ; P 0.01). When dPadt was normalized for developed pressure, the difference between control and forskolin-stimulated conditions was 46% higher in lean rabbits than obese rabbits (7.0AE 1.0 [mmHgas]ammHg vs 4.8 AE 0. 6 [mmHgasec]ammHg, respectively) (P 0.09). When 7 dPadt was normalized for developed pressure, the difference between control and forskolin-stimulated conditions was 21% greater in lean than obese rabbits (4.7AE 0. 
Discussion
We have previously demonstrated that rabbits fed an ad libitum high fat diet develop systolic contractile abnormalities in response to b-stimulation, as evidenced by a reduced response to isoproterenol in both isolated heart and isolated papillary muscle preparations. 11 The present study extends that work and suggests that there is a defect in the post-receptor signaling system that affects both contractility and relaxation. Isolated hearts of obese rabbits, exhibited decreased peak developed pressure, dPadt and 7 dPadt in response to forskolin infusion. Since forskolin bypasses the b-receptoraG-protein complex to directly stimulate adenylate cyclase, this suggests that systolic dysfunction in obesity may be associated with at least one defect in post-b-receptor signaling pathways.
The interaction of a b-agonist with its receptor on the cardiac myocyte activates the guanine nucleotide stimulatory protein a (G sa ) protein, which in turn activates adenylate cyclase and results in increased intracellular adenosine 3 H : 5 H -cyclic monophosphate (cAMP). Subsequent cellular reactions simultaneously affect contractility and relaxation of the heart. 12 Positive inotropy in response to b-stimulation involves several pathways: a) phosphorylation of plasma membrane calcium channels by protein kinase A increases calcium entry into the cell, b) phosphorylation of phospholamban increases calcium stores in the sarcoplasmic reticulum (SR), and c) increased shortening velocity of actomyosin increases crossbridge cycling.
b-stimulation also has lusitropic effects on the heart; this is essential to resequester calcium at a more rapid rate in the face of increased calcium entry. Speci®cally, lusitropic effects of b-stimulation include a) phosphorylation of the sodium pump in the plasma membrane which increases calcium ef¯ux via the sodiumacalcium exchanger, b) phosphorylation of phospholamban, which increases SR calcium pump turnover and sensitivity, thereby accelerating removal of calcium from the cytoplasm, and c) phosphorylation of troponin I which decreases calcium senstivity of the troponin complex, resulting in decreased calcium binding. 12 The results of the present study do not identify which step(s) in the signaling pathway is (are) de®-cient. In pressure overload models of cardiac hypertrophy, one or more components of the b-receptorcAMP pathway have been implicated in reduced contractile responses. 5, 7 In addition, the present results do not eliminate the possibility that defects in breceptor number or sensitivity are also involved in the reduced responsiveness to isoproterenol inobe- Data are presented as mean AE SEM; *P 0.01, greater than corresponding control value (paired t-test); **P 0.05, lean b obese (ANOVA); *** P 0.01, lean b obese (ANOVA). dPadt maximal rate of pressure rise; 7 dPadt maximal rate of pressure decline.
Cardiac post-b-receptor defect in obesity JF Carroll sity. 9 Indeed, b-adrenergic receptor number and altered coupling between receptors and guanine nucleotide stimulatory protein (G s ) have been demonstrated to be impaired in the obese Zucker rat. 13 In addition, decreases in b-receptor number and af®nity, as well as decreased cAMP production, were demonstrated in an obese, hypertensive rat model.
14 While these studies offer clues to the mechanisms responsible for reduced responsiveness to b-adrenergic stimulation, there are differences regarding the contributions of various components of the signaling pathway to systolic dysfunction. These discrepancies may arise from the presence or absence of hypertension, hypertrophy 14 andaor obesity in the model, 5, 7 from differences in non-haemodynamic factors, such as activation of the renin-angiotensin system, sodium intake, or catecholamine concentrations, as well as from the age, strain or species of the animal model used. Using a model, such as the obese rabbit, which consistently mimics many cardiovascular and neurohumoral abnormalities of human obesity, may provide more conclusive answers regarding the impact of obesity on systolic dysfunction.
We have preliminary data to suggest that messenger ribonucleic acid (mRNA) and protein for sarcoplasmic reticulum calcium adenosine triphosphatase (SERCA2a) and the sodiumacalcium exchanger are increased in this model. 15 Paradoxically, this suggests that relaxation might be enhanced in obesity, due to increases in both calcium ef¯ux from the cell and calcium resequestration by the SR. However, data from this and a previous study, 16 suggest that this is not the case. The stimulus for enhanced capacity for calcium ef¯uxaresequestration is not yet known, but may be related to increased work performed by hearts of obese rabbits. Heart rate 10, 11, 15, 16 and rate-pressure product 15 are chronically increased in obese rabbits. The increased rate shortens the time for relaxation and may promote greater overall capacity for calcium ef¯ux andaor resequestration. Alternately, there may be a reduced activity or sensitivity of plasma membrane soldiumacalcium and SR calcium pumps, which might induce upregulation of pump number. Nevertheless, despite overall enhanced calcium handling potential, the present data suggest that relaxation per individual heart beat remains impaired in obesity.
Conclusion
In summary, our data demonstrate that there is a defect in the cardiac myocyte post-b-receptor signaling pathway in the isolated hearts of obese rabbits. This was evidenced by reduced peak developed pressure, dPadt, and 7 dPadt responses to forskolin stimulation. Thus, the de®ciency affects both contractility and relaxation. Further research is needed to localize the defect(s), in order to devise therapies to reduce the impact of obesity on heart function.
